<< A drug derived from an ocean-growing sponge helps prevent the growth of cancer cells | New guidelines for antiretroviral drugs to prevent the transmission of HIV from mothers to their children >>
Read in | English | Español | Français | Português | 简体中文 | Nederlands | Bahasa | Русский | Svenska | Polski

Targeted therapeutics capable of preventing or limiting the metastasis of skin cancer

Published on July 15, 2004 at 8:01 AM · No Comments

An international team of scientists has identified an important molecular link involved in the spread – or metastasis – of melanoma to other organs such as the lungs.

By introducing a synthetic peptide that mimics one component of this link, the researchers blocked this cellular interaction, significantly deterring the migration of cancer cells beyond the original tumor site. Blocking this protein linkage also was shown to inhibit angiogenesis--the creation of blood vessels that nourish new, secondary tumors--and spur cell death or apoptosis.

The results, published in the July issue of the journal Cancer Research, open the door to the prospect of targeted therapeutics capable of preventing or limiting the metastasis of skin cancer.

"The ability of these synthetic peptides to reduce tumor cell metastasis and angiogenesis and increase apoptosis may be important in the development of therapeutics for malignancy," said Hynda Kleinman, Ph.D., chief, cell biology section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Md.

As described in their study, the spread of melanoma cancer cells requires the interaction of two proteins, one located on the cell's surface called CD44, and an extracellular matrix protein known as laminin á5.

CD44 is considered a proteogylcan, which is a protein that has lengthy chains of carbohydrates that extend outward from its protein core, giving it a structure similar to a bottle brush. Carbohydrate side chains, called glycosaminoglycans (GAGs), can interact with other molecules outside of the cell wall membrane. CD44 is produced by cells and positioned on their cell surface membrane. It is often overexpressed in cancer cells. Dr. Kleinman and her associates determined that the GAG near one end of the CD44 protein backbone binds to a specific sequence of amino acid residues in laminin á5.

The laminin á5 molecule is an extracellular matrix protein that occupies areas between cells in the body and gives definition and structural identity to organs and tissue.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading